Heart Pump Device Market by Product (Ventricular Assist Devices (LVAD, RVAD, BiVAD, and pVAD), Intra-aortic Balloon Pumps, TAH), Type (Extracorporeal and Implantable Pumps), Therapy (Bridge-to-transplant, Destination Therapy) - Global Forecast to 2026

世界の心臓ポンプ装置市場予測:製品別、種類別、治療法別

◆タイトル:Heart Pump Device Market by Product (Ventricular Assist Devices (LVAD, RVAD, BiVAD, and pVAD), Intra-aortic Balloon Pumps, TAH), Type (Extracorporeal and Implantable Pumps), Therapy (Bridge-to-transplant, Destination Therapy) - Global Forecast to 2026
◆商品コード:MD6265
◆調査・発行会社:MarketsandMarkets
◆発行日:2021年5月25日
◆ページ数:174
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社は、世界の心臓ポンプ装置市場規模が2021年21億ドルから2026年55億ドルまで、年平均21.6%成長すると予測しています。本調査レポートでは、心臓ポンプ装置の世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(心室補助装置、動脈内バルーンポンプ、完全置換型人工心臓)分析、種類別(体外式心臓ポンプ装置、埋め込み式心臓ポンプ装置)分析、治療法別(BTT、BTC、デスティネーションセラピー、その他) 分析、地域別分析、競争状況、企業情報などを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の心臓ポンプ装置市場規模:製品別(心室補助装置、動脈内バルーンポンプ、完全置換型人工心臓)
・世界の心臓ポンプ装置市場規模:種類別(体外式心臓ポンプ装置、埋め込み式心臓ポンプ装置)
・世界の心臓ポンプ装置市場規模:治療法別(BTT、BTC、デスティネーションセラピー、その他)
・世界の心臓ポンプ装置市場規模:地域別
・競争状況
・企業情報

“The global heart pump device market is projected to USD 5.5 billion by 2026 from USD 2.1 billion in 2021, at a CAGR of 21.6% from 2021 to 2026.”
The growth of this market is driven owing to increasing investments, funds, and grants for research on heart failure treatment; rising prevalence of cardiovascular diseases; long waiting periods for heart transplants; favorable reimbursements for heart pump devices; and increasing obesity. Also, promising product pipeline, increasing number of product approvals and emerging markets are anticipated to offer an opportunity for the growth of the market during the forecast period.

“Ventricular assist devices are expected to hold the largest share of the heart pump device market, by product in 2021.”
Based on products, the heart pump devices market is segmented into ventricular assist devices, intra- aortic balloon pumps, and total artificial hearts. Ventricular assist devices are the largest and fastest-growing segment in this market. Growth in this segment can primarily be attributed to technological advancements, the shortage of organ donors, and the increasing prevalence of heart failure globally.

“Implantable heart pump devices are expected to hold the largest share of the heart pump device market, by type in 2021.”
Based on type, the market is segmented into implantable heart pump devices and extracorporeal heart pump devices. In 2020, implantable heart pump devices accounted for the largest share of this market, due to the introduction of innovative products by leading players and the rising need for an efficient solution to manage heart failure.

“Bridge-to-transplant is expected to hold the largest share of the heart pump device market, by therapy in 2021.”
Based on therapy, the market is segmented into bridge-to-transplant (BTT), bridge-to-candidacy (BTC), destination therapy (DT), and other therapies. In 2020, the BTT segment accounted for the largest share of this market. Growing awareness about transplantation and the availability of VADs for BTT have propelled the growth of this segment.

“Europe commanded the largest share of the heart pump device market in 2021.”
On the basis of region, the heart pump device market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2020, Europe commanded the largest share of the heart pump device market. The large share of this market segment can be attributed to the rising adoption of heart pump devices, the high prevalence of CVDs, the growing number of research activities to improve current technologies, and the limited availability of donor hearts for transplants.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (33%), Europe (24%), AsiaPacific (27%), and Rest of the World (16%)

Some of the major players operating in this market are Abbott Laboratories (US), Abiomed (US), Medtronic (Ireland), Teleflex Incorporated (US), and Fresenius Medical Care AG & Co. KGaA (Germany)

List of Companies Profiled in the Report
• Abbott Laboratories (US)
• Abiomed (US)
• Medtronic (Ireland)
• Teleflex Incorporated (US)
• SynCardia Systems (US)
• Fresenius Medical Care AG & Co. KGaA (Germany)
• Getinge (Sweden)
• CardiacAssist, Inc. (US)
• Berlin Heart (Germany)
• Jarvik Heart, Inc. (US)
• CARMAT (France)
• SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. (Japan)
• Angiodroid (Italy)
• CardioDyme (US)
• World Heart Corporation (US).

Research Coverage
This report studies the heart pump device market based on product, type, therapy, and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total heart pump device market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on heart pump device offered by the top 15 players in the heart pump device market. The report analyzes the heart pump device market product, type, therapy, and region.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the heart pump device market
• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the heart pump device market

Frequently asked questions
• What are the growth opportunities in the heart pump device market across major regions in the future?
• Which product is expected to hold the largest share in the heart pump device market?
• Which region is anticipated to witness considerable growth in the heart pump device market?
• Which are the driving factors of the heart pump device market?
• What is the impact of COVID-19 on the heart pump device market?

【レポートの目次】

1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 28
1.3 MARKET SCOPE 28
1.3.1 MARKETS COVERED 28
FIGURE 1 HEART PUMP DEVICES: MARKET SEGMENTATION 28
1.3.2 YEARS CONSIDERED FOR THE STUDY 29
1.4 CURRENCY 29
1.5 LIMITATIONS 29
1.6 STAKEHOLDERS 29
1.7 SUMMARY OF CHANGES 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
FIGURE 2 RESEARCH DESIGN 31
2.1.1 SECONDARY DATA 32
2.1.1.1 Key data from secondary sources 32
2.1.2 PRIMARY DATA 33
FIGURE 3 PRIMARY SOURCES 33
2.1.2.1 Key data from primary sources 34
2.1.2.2 Key industry insights 35
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 35
2.2 MARKET SIZE ESTIMATION 36
FIGURE 5 BOTTOM-UP APPROACH 36
FIGURE 6 APPROACH 3: PARENT MARKET ANALYSIS [ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET] 37
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38
FIGURE 8 TOP-DOWN APPROACH 39
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 40
FIGURE 9 DATA TRIANGULATION METHODOLOGY 40
2.4 MARKET SHARE ANALYSIS 40
2.5 ASSUMPTIONS FOR THE STUDY 41
2.6 COVID-19 ECONOMIC ASSESSMENT 41
2.7 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 42
FIGURE 10 CRITERIA IMPACTING THE GLOBAL ECONOMY 42
FIGURE 11 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 43

3 EXECUTIVE SUMMARY 44
FIGURE 12 HEART PUMP DEVICES MARKET, BY PRODUCT, 2021 VS. 2026 (USD BILLION) 44
FIGURE 13 HEART PUMP DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION) 45
FIGURE 14 HEART PUMP DEVICES MARKET, BY THERAPY, 2021 VS. 2026 (USD BILLION) 45
FIGURE 15 HEART PUMP DEVICES MARKET, BY REGION, 2021 VS. 2026 (USD BILLION) 46
4 PREMIUM INSIGHTS 47
4.1 HEART PUMP DEVICES MARKET OVERVIEW 47
FIGURE 16 THE RISING INCIDENCE OF HEART FAILURE IS A MAJOR FACTOR DRIVING THE GROWTH OF THE HEART PUMP DEVICES MARKET 47
4.2 EUROPE: HEART PUMP DEVICES MARKET SHARE, BY THERAPY (2020) 48
FIGURE 17 BTT THERAPY SEGMENT DOMINATED THE EUROPEAN MARKET IN 2020 48
4.3 GEOGRAPHICAL SNAPSHOT OF THE HEART PUMP DEVICES MARKET 49
FIGURE 18 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 49
5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
5.2 MARKET DYNAMICS 50
FIGURE 19 HEART PUMP DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
5.2.1 DRIVERS 51
5.2.1.1 Increasing investments, funds, and grants for research on heart failure treatment 51
5.2.1.2 Rising prevalence of cardiovascular diseases 51
FIGURE 20 SHARE OF GLOBAL POPULATION AGED 65 AND ABOVE (2015–2019) 52
5.2.1.3 Long waiting periods for heart transplant procedures 52
5.2.1.4 Favorable reimbursements for heart pump devices 53
TABLE 1 CPT CODES FOR PROCEDURES RELATED TO VENTRICULAR ASSIST DEVICES AND TAH 53
TABLE 2 CPT CODES FOR PROCEDURES RELATED TO IABP 53
5.2.1.5 Increasing prevalence of obesity 54
5.2.2 RESTRAINTS 54
5.2.2.1 Complications associated with LVAD implantations 54
5.2.2.2 Lack of funding for destination therapy 55
5.2.3 OPPORTUNITIES 56
5.2.3.1 Promising product pipeline 56
TABLE 3 TOTAL ARTIFICIAL HEARTS IN PIPELINE 56
5.2.3.2 Increasing number of product approvals 57
TABLE 4 RECENT APPROVALS IN THE HEART PUMP DEVICES MARKET, 2018–2020 57
5.2.3.3 Emerging markets 57
5.2.4 CHALLENGES 58
5.2.4.1 Frequent product recalls 58
TABLE 5 KEY PRODUCT RECALLS IN THE HEART PUMP DEVICES MARKET 58
5.2.4.2 Stringent regulatory requirements delaying the approval of cardiac devices 58
5.3 SUPPLY CHAIN ANALYSIS 59
FIGURE 21 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY OF PROMINENT COMPANIES 60
5.4 VALUE CHAIN ANALYSIS 60
FIGURE 22 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES 60
5.5 ECOSYSTEM ANALYSIS 61
FIGURE 23 ECOSYSTEM ANALYSIS OF THE HEART PUMP DEVICES INDUSTRY 61
5.5.1 ROLE IN THE ECOSYSTEM 62
5.6 REGULATORY LANDSCAPE 62
TABLE 6 LIST OF REGULATORY AUTHORITIES 63
5.6.1 EU REGULATIONS 63
5.6.2 US REGULATIONS 64
5.7 PORTER’S FIVE FORCES ANALYSIS 64
5.7.1 THREAT FROM NEW ENTRANTS 64
5.7.2 BARGAINING POWER OF SUPPLIERS 64
5.7.3 BARGAINING POWER OF BUYERS 64
5.7.4 INTENSITY OF COMPETITIVE RIVALRY 65
5.7.5 THREAT FROM SUBSTITUTES 65
5.8 COVID-19 IMPACT ANALYSIS FOR THE HEART PUMP DEVICES MARKET 65
FIGURE 24 PERCENTAGE OF MEDTRONIC’S CARDIAC AND VASCULAR GROUP NET SALES, BY DIVISION, FY 2019 VS. FY 2020 66
5.9 PATENT ANALYSIS 67
5.9.1 VENTRICULAR ASSIST DEVICES 67
5.9.2 TOTAL ARTIFICIAL HEARTS 67
5.9.3 INTRA-AORTIC BALLOON PUMPS 68
5.10 TRADE ANALYSIS 68
5.10.1 IMPORT DATA, BY COUNTRY, 2017–2019 (USD MILLION) 68
5.10.2 EXPORT DATA, BY COUNTRY, 2017–2019 (USD MILLION) 69
5.10.3 EXPORT DATA, BY COUNTRY, 2017–2019 (KILOGRAMS) 70
5.10.4 IMPORT DATA, BY COUNTRY, 2017–2019 (KILOGRAMS) 70
5.11 TECHNOLOGY ANALYSIS 70
5.12 AVERAGE SELLING PRICE TREND 71
TABLE 7 AVERAGE SELLING PRICES OF HEART PUMP DEVICE PRODUCTS 71
5.13 YCC SHIFT 72
6 HEART PUMP DEVICES MARKET, BY PRODUCT 73
6.1 INTRODUCTION 74
TABLE 8 HEART PUMP DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 74

6.2 VENTRICULAR ASSIST DEVICES 74
TABLE 9 VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 75
TABLE 10 VENTRICULAR ASSIST DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 75
6.2.1 LEFT VENTRICULAR ASSIST DEVICES 75
6.2.1.1 LVADs are the most common types of VAD used—a key factor driving market growth 75
TABLE 11 LEFT VENTRICULAR ASSIST DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 76
6.2.2 PERCUTANEOUS VENTRICULAR ASSIST DEVICES 76
6.2.2.1 Ability to provide efficient cardiac support to drive the growth of this market segment 76
TABLE 12 PERCUTANEOUS VENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 77
6.2.3 BIVENTRICULAR ASSIST DEVICES 77
6.2.3.1 Lack of reimbursement for BiVAD to restrict market growth to a certain extent 77
TABLE 13 BIVENTRICULAR ASSIST DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 78
6.2.4 RIGHT VENTRICULAR ASSIST DEVICES 78
6.2.4.1 RVADs are used as temporary cardiac assist devices 78
TABLE 14 RIGHT VENTRICULAR ASSIST DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 78
6.3 INTRA-AORTIC BALLOON PUMPS 79
6.3.1 INCREASING RECALLS OF IABPS TO HINDER THE MARKET GROWTH 79
TABLE 15 RECENT IABP RECALLS IN THE HEART PUMP DEVICES MARKET 79
TABLE 16 INTRA-AORTIC BALLOON PUMPS MARKET, BY REGION,
2019–2026 (USD MILLION) 80
6.4 TOTAL ARTIFICIAL HEARTS 80
6.4.1 LAUNCH OF INNOVATIVE PRODUCTS TO ACCELERATE GROWTH IN THIS PRODUCT SEGMENT 80
TABLE 17 TOTAL ARTIFICIAL HEARTS MARKET, BY REGION, 2019–2026 (USD MILLION) 81
7 HEART PUMP DEVICES MARKET, BY TYPE 82
7.1 INTRODUCTION 83
TABLE 18 HEART PUMP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 83
7.2 IMPLANTABLE HEART PUMP DEVICES 83
7.2.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE GROWTH IN THIS MARKET SEGMENT 83
TABLE 19 IMPLANTABLE HEART PUMP DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 84
7.3 EXTRACORPOREAL HEART PUMP DEVICES 84
7.3.1 EXTRACORPOREAL HEART PUMP DEVICES CAN BE USED IN PEDIATRIC PATIENTS—A KEY FACTOR DRIVING MARKET GROWTH 84
TABLE 20 EXTRACORPOREAL HEART PUMP DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 85
8 HEART PUMP DEVICES MARKET, BY THERAPY 86
8.1 INTRODUCTION 87
TABLE 21 HEART PUMP DEVICES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 87
8.2 BRIDGE-TO-TRANSPLANT (BTT) 87
8.2.1 GROWING NUMBER OF PATIENTS ON THE WAITING LIST TO SUPPORT MARKET GROWTH 87
TABLE 22 HEART PUMP DEVICES MARKET FOR BRIDGE-TO-TRANSPLANT THERAPY,
BY REGION, 2019–2026 (USD MILLION) 88
8.3 BRIDGE-TO-CANDIDACY (BTC) 88
8.3.1 EFFICIENT OUTCOMES PROVIDED BY BTC TO PROPEL MARKET GROWTH 88
TABLE 23 HEART PUMP DEVICES MARKET FOR BRIDGE-TO-CANDIDACY THERAPY,
BY REGION, 2019–2026 (USD MILLION) 89
8.4 DESTINATION THERAPY (DT) 89
8.4.1 INTRODUCTION OF INNOVATIVE TECHNOLOGIES TO ACCELERATE SEGMENTAL GROWTH 89
TABLE 24 HEART PUMP DEVICES MARKET FOR DESTINATION THERAPY, BY REGION, 2019–2026 (USD MILLION) 90
8.5 OTHER THERAPIES 90
TABLE 25 HEART PUMP DEVICES MARKET FOR OTHER THERAPIES, BY REGION,
2019–2026 (USD MILLION) 90
9 HEART PUMP DEVICES MARKET, BY REGION 91
9.1 INTRODUCTION 92
TABLE 26 HEART PUMP DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 92
9.2 NORTH AMERICA 92
TABLE 27 NORTH AMERICA: HEART PUMP DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 92
TABLE 28 NORTH AMERICA: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 93
TABLE 29 NORTH AMERICA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 93
TABLE 30 NORTH AMERICA: HEART PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 93
TABLE 31 NORTH AMERICA: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 94
9.2.1 US 94
9.2.1.1 Availability of reimbursements to support market growth 94
TABLE 32 CPT CODES FOR PROCEDURES RELATED TO VAD AND TAH 94
TABLE 33 US: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 95
TABLE 34 US: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 96
TABLE 35 US: HEART PUMP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 96
TABLE 36 US: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 96

9.2.2 CANADA 97
9.2.2.1 Rising incidence and prevalence of heart failure to propel market growth 97
TABLE 37 CANADA: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 97
TABLE 38 CANADA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 97
TABLE 39 CANADA: HEART PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 98
TABLE 40 CANADA: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 98
9.3 EUROPE 99
FIGURE 25 EUROPE: HEART PUMP DEVICES MARKET SNAPSHOT 99
TABLE 41 EUROPE: HEART PUMP DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 100
TABLE 42 EUROPE: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 100
TABLE 43 EUROPE: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 100
TABLE 44 EUROPE: HEART PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 101
TABLE 45 EUROPE: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 101
9.3.1 GERMANY 101
9.3.1.1 High adoption of VADs as destination therapy in Germany to drive market growth 101
TABLE 46 GERMANY: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019-2026 (USD MILLION) 102
TABLE 47 GERMANY: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 103
TABLE 48 GERMANY: HEART PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 103
TABLE 49 GERMANY: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 103
9.3.2 UK 104
9.3.2.1 Long waiting list for heart transplants in the UK 104
TABLE 50 UK: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 104
TABLE 51 UK: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 105
TABLE 52 UK: HEART PUMP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 105
TABLE 53 UK: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 105
9.3.3 FRANCE 106
9.3.3.1 Developments undertaken by local players to accelerate market growth in France 106
TABLE 54 FRANCE: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019-2026 (USD MILLION) 106
TABLE 55 FRANCE: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 107
TABLE 56 FRANCE: HEART PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 107
TABLE 57 FRANCE: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 107
9.3.4 ITALY 108
9.3.4.1 Initiatives undertaken by local players to drive market growth in Italy 108
TABLE 58 ITALY: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 108
TABLE 59 ITALY: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 108
TABLE 60 ITALY: HEART PUMP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 109
TABLE 61 ITALY: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 109
9.3.5 SPAIN 109
9.3.5.1 Rising geriatric population to propel market growth in Spain 109
TABLE 62 SPAIN: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 110
TABLE 63 SPAIN: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 110
TABLE 64 SPAIN: HEART PUMP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 110
TABLE 65 SPAIN: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 111
9.3.6 REST OF EUROPE 111
TABLE 66 PERCENTAGE OF POPULATION AGED 60 YEARS OR OVER, 2017 VS. 2050 111
TABLE 67 ROE: HEALTH EXPENDITURE (% OF GDP), 2010 VS. 2017 112
TABLE 68 ROE: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 112
TABLE 69 ROE: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 112
TABLE 70 ROE: HEART PUMP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 113
TABLE 71 ROE: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 113
9.4 ASIA PACIFIC 114
FIGURE 26 ASIA PACIFIC: HEART PUMP DEVICES MARKET SNAPSHOT 114
TABLE 72 ASIA PACIFIC: HEART PUMP DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 115
TABLE 73 ASIA PACIFIC: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 115
TABLE 74 ASIA PACIFIC: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 115
TABLE 75 ASIA PACIFIC: HEART PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 116
TABLE 76 ASIA PACIFIC: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 116

9.4.1 JAPAN 116
9.4.1.1 Low rate of transplantations in the country to drive market growth 116
TABLE 77 JAPAN: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 117
TABLE 78 JAPAN: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 117
TABLE 79 JAPAN: HEART PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 117
TABLE 80 JAPAN: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 118
9.4.2 CHINA 118
9.4.2.1 High prevalence of CVDs in China to drive market growth 118
TABLE 81 CHINA: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 119
TABLE 82 CHINA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 119
TABLE 83 CHINA: HEART PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 119
TABLE 84 CHINA: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 120
9.4.3 INDIA 120
9.4.3.1 Huge target population in India to drive market growth 120
TABLE 85 INDIA: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (US MILLION) 121
TABLE 86 INDIA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 121
TABLE 87 INDIA: HEART PUMP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 88 INDIA: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 122
9.4.4 AUSTRALIA 122
9.4.4.1 Increasing prevalence of heart disease to accelerate market growth in Australia 122
TABLE 89 AUSTRALIA: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 122
TABLE 90 AUSTRALIA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 123
TABLE 91 AUSTRALIA: HEART PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 123
TABLE 92 AUSTRALIA: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 123
9.4.5 REST OF ASIA PACIFIC 124
TABLE 93 ROAPAC: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 124
TABLE 94 ROAPAC: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 124
TABLE 95 ROAPAC: HEART PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 96 ROAPAC: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 125
9.5 REST OF THE WORLD 125
TABLE 97 REST OF THE WORLD: HEART PUMP DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 125
TABLE 98 REST OF THE WORLD: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 126
TABLE 99 REST OF THE WORLD: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 126
TABLE 100 REST OF THE WORLD: HEART PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 126
TABLE 101 REST OF THE WORLD: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 127
9.5.1 MIDDLE EAST & AFRICA 127
9.5.1.1 Increasing adoption of heart pump devices in the region to drive market growth 127
TABLE 102 MIDDLE EAST & AFRICA: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 128
TABLE 103 MIDDLE EAST & AFRICA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 128
TABLE 104 MIDDLE EAST & AFRICA: HEART PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 128
TABLE 105 MIDDLE EAST & AFRICA: HEART PUMP DEVICES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 129
9.5.2 LATIN AMERICA 129
9.5.2.1 Rising geriatric population to increase the demand for heart pump devices in the region 129
TABLE 106 LATIN AMERICA: HEART PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 130
TABLE 107 LATIN AMERICA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 130
TABLE 108 LATIN AMERICA: HEART PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 130
TABLE 109 LATIN AMERICA: HEART PUMP DEVICES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 131
10 COMPETITIVE LANDSCAPE 132
10.1 OVERVIEW 132
FIGURE 27 KEY DEVELOPMENTS IN THE HEART PUMP DEVICES MARKET, JANUARY 2018–APRIL 2021 132
FIGURE 28 MARKET EVOLUTION MATRIX: JANUARY 2018 TO APRIL 2021 133
10.2 REVENUE ANALYSIS 133
10.2.1 HEART PUMP DEVICES MARKET: REVENUE ANALYSIS OF THE TOP 5 MARKET PLAYERS 133
FIGURE 29 TOP 5 PLAYERS HAVE DOMINATED THE MARKET IN THE LAST 3 YEARS 133
10.3 MARKET SHARE ANALYSIS 134
TABLE 110 HEART PUMP DEVICES MARKET: DEGREE OF COMPETITION 134
10.4 COMPANY EVALUATION MATRIX 135
10.4.1 STARS 135
10.4.2 EMERGING LEADERS 135
10.4.3 PERVASIVE PLAYERS 135
10.4.4 PARTICIPANTS 135
FIGURE 30 VENDOR DIVE: HEART PUMP DEVICES MARKET 136
10.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES) 137
10.5.1 PROGRESSIVE COMPANIES 137
10.5.2 STARTING BLOCKS 137
10.5.3 RESPONSIVE COMPANIES 137
10.5.4 DYNAMIC COMPANIES 137
FIGURE 31 HEART PUMP DEVICES MARKET: VENDOR DIVE MATRIX FOR SMES AND START-UPS, 2020 138
10.6 COMPETITIVE SCENARIO 139
10.6.1 PRODUCT APPROVALS 139
TABLE 111 KEY PRODUCT APPROVALS, JANUARY 2018–APRIL 2021 139
10.6.2 DEALS 139
TABLE 112 KEY DEALS, JANUARY 2018–APRIL 2021 139
10.6.3 OTHER DEVELOPMENTS 140
TABLE 113 OTHER KEY DEVELOPMENTS, JANUARY 2018–APRIL 2021 140
10.7 COMPANY FOOTPRINT 140
TABLE 114 COMPANY FOOTPRINT 140
TABLE 115 COMPANY PRODUCT FOOTPRINT 141
TABLE 116 COMPANY TYPE FOOTPRINT 142
TABLE 117 COMPANY GEOGRAPHICAL FOOTPRINT 143
11 COMPANY PROFILES 144
11.1 KEY PLAYERS 144
(Business Overview, Products/Solutions Offered, Recent Developments, SWOT Analysis, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win)*
11.1.1 ABBOTT LABORATORIES 144
TABLE 118 ABBOTT LABORATORIES: BUSINESS OVERVIEW 144
FIGURE 32 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020) 145
11.1.2 ABIOMED 147
TABLE 119 ABIOMED: BUSINESS OVERVIEW 147
FIGURE 33 ABIOMED: COMPANY SNAPSHOT (2020) 148
11.1.3 MEDTRONIC 150
TABLE 120 MEDTRONIC: BUSINESS OVERVIEW 150
FIGURE 34 MEDTRONIC: COMPANY SNAPSHOT (2020) 151
11.1.4 TELEFLEX INCORPORATED 153
TABLE 121 TELEFLEX INCORPORATED: BUSINESS OVERVIEW 153
FIGURE 35 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2020) 153
11.1.5 SYNCARDIA SYSTEMS 155
TABLE 122 SYNCARDIA SYSTEMS: BUSINESS OVERVIEW 155
11.1.6 FRESENIUS MEDICAL CARE AG & CO. KGAA 157
TABLE 123 FRESENIUS MEDICAL CARE AG & CO. KGAA: BUSINESS OVERVIEW 157
FIGURE 36 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT (2020) 158
11.1.7 CARDIACASSIST, INC. 159
TABLE 124 CARDIACASSIST, INC.: BUSINESS OVERVIEW 159
FIGURE 37 LIVANOVA PLC: COMPANY SNAPSHOT (2020) 159
11.1.8 GETINGE 161
TABLE 125 GETINGE: BUSINESS OVERVIEW 161
FIGURE 38 GETINGE: COMPANY SNAPSHOT (2020) 161
11.2 OTHER PLAYERS 163
11.2.1 BERLIN HEART 163
TABLE 126 BERLIN HEART: BUSINESS OVERVIEW 163
11.2.2 JARVIK HEART, INC. 165
TABLE 127 JARVIK HEART, INC.: BUSINESS OVERVIEW 165
11.2.3 CARMAT 166
TABLE 128 CARMAT: BUSINESS OVERVIEW 166
11.2.4 SENKO MEDICAL INSTRUMENT MFG. CO., LTD. 167
TABLE 129 MERA: BUSINESS OVERVIEW 167
11.2.5 ANGIODROID 168
TABLE 130 ANGIODROID: BUSINESS OVERVIEW 168
11.2.6 CARDIODYME 169
TABLE 131 CARDIODYME: BUSINESS OVERVIEW 169
11.2.7 WORLD HEART CORPORATION 170
TABLE 132 WORLD HEART CORPORATION: BUSINESS OVERVIEW 170
*Business Overview, Products/Solutions Offered, Recent Developments, SWOT Analysis, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win might not be captured in case of unlisted companies.
12 APPENDIX 171
12.1 INSIGHTS FROM INDUSTRY EXPERTS 171
12.2 DISCUSSION GUIDE 172
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 176
12.4 AVAILABLE CUSTOMIZATIONS 178
12.5 RELATED REPORTS 178
12.6 AUTHOR DETAILS 179



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の心臓ポンプ装置市場予測:製品別、種類別、治療法別]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆